Zydus Lifesciences plans to raise up to Rs 5,000 crore

Fund Raising View source PDF Explain this filing

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.0%Reaction day

₹973.40

prior close

₹958.00

announcement price

In-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)-0.5%-3.5% vs market

Pharmaceuticals peers, median of 156sector-1.1%-2.9% vs sector

On the reaction day the stock moved 3.5 pts less than Nifty 100 and 2.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.8

10m

+0.5

15m

+0.5

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.0-0.5-3.5-1.1-2.9

Next day

-2.9-0.5-2.4-1.4-1.6

-2.7-0.2-2.5-2.0-0.7

-3.6+0.2-3.8-2.3-1.3

-2.3+0.8-3.1-1.2-1.1

-2.9+0.8-3.7-1.5-1.4

-3.9+1.4-5.3-1.7-2.3

15d

-3.5+1.7-5.3-4.3+0.8

-5.3+0.5-5.8-7.0+1.7

-4.3+2.0-6.3-5.2+0.9

-8.9+0.0-8.9-9.1+0.3

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved raising up to Rs 5,000 crore through institutional placements, a rights issue, preferential allotment, private placement, or a combination. The route, investors, securities, pricing and timing have not been decided. Shareholder and regulatory approvals are required, and a postal ballot notice will follow.

Likely market impact

The fund raise may support company finances, but the route and pricing are unknown. Any equity issue could dilute existing shareholders.